{"adverse_reactions":["Sincerus Florida, LLC adverse reactions. g"],"components":["Active Inactive h"],"effective_time":"20190423","id":"8738c9c8-17b2-b7b7-e053-2a91aa0acdfb","instructions_for_use":["Directions for use s"],"openfda":{},"package_label_principal_display_panel":["NDC 72934-2061-2 NIACINAMIDE 4 / TAZAROTENE 0.01 Cream 30gm z"],"set_id":"8738c9c8-17b1-b7b7-e053-2a91aa0acdfb","spl_product_data_elements":["NIACINAMIDE 4% / TAZAROTENE 0.1% NIACINAMIDE 4% / TAZAROTENE 0.1% TAZAROTENE TAZAROTENE NIACINAMIDE NIACINAMIDE"],"version":"1"}